Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Sakurada

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Retinal Cases & Brief Reports|July 27, 2019
RESOLUTION OF A SUBFOVEAL CHOROIDAL CAVERN AFTER HALF-DOSE PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHYYoichi Sakurada, Ravi Parikh, K Bailey Freund
Ophthalmology|March 24, 2018
Multimodal Imaging in Adult-Onset Coats' DiseaseYoichi Sakurada, K Bailey Freund, Lawrence A Yannuzzi
Retina (Philadelphia, Pa.)|February 13, 2013
Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degenerationYoichi Sakurada, Seigo Yoneyama, Mitsuhiro Imasawa, et al.
Medicine|December 9, 2022
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case reportShuhei Hosoda, Yoichi Sakurada, Taiyo Shijo, et al.
Japanese Journal of Ophthalmology|December 21, 2011
Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumabNarihisa Hanada, Hiroyuki Iijima, Yoichi Sakurada, et al.
Japanese Journal of Ophthalmology|April 9, 2025
Long-term outcomes and the association between early detection of retinal pigment epithelial atrophy and remission after loading dose in eyes with retinal angiomatous proliferationWataru Kikushima, Yoichi Sakurada, Daphne Viel Tsuru, et al.
Cureus|August 1, 2024
Familial Occurrence of a Severe Phenotype of Central Serous Chorioretinopathy in Two BrothersYuta Inada, Yoichi Sakurada, Taiyo Shijo, et al.
Scientific Reports|January 25, 2026
Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotypeYoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal VasculopathyYoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular EdemaWataru Kikushima, Taiyo Shijo, Yukiko Furuhata, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Retinal Cases & Brief Reports|July 27, 2019
RESOLUTION OF A SUBFOVEAL CHOROIDAL CAVERN AFTER HALF-DOSE PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHYYoichi Sakurada, Ravi Parikh, K Bailey Freund
Ophthalmology|March 24, 2018
Multimodal Imaging in Adult-Onset Coats' DiseaseYoichi Sakurada, K Bailey Freund, Lawrence A Yannuzzi
Retina (Philadelphia, Pa.)|February 13, 2013
Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degenerationYoichi Sakurada, Seigo Yoneyama, Mitsuhiro Imasawa, et al.
Medicine|December 9, 2022
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case reportShuhei Hosoda, Yoichi Sakurada, Taiyo Shijo, et al.
Japanese Journal of Ophthalmology|December 21, 2011
Recurrence of macular edema associated with branch retinal vein occlusion after intravitreal bevacizumabNarihisa Hanada, Hiroyuki Iijima, Yoichi Sakurada, et al.
Japanese Journal of Ophthalmology|April 9, 2025
Long-term outcomes and the association between early detection of retinal pigment epithelial atrophy and remission after loading dose in eyes with retinal angiomatous proliferationWataru Kikushima, Yoichi Sakurada, Daphne Viel Tsuru, et al.
Cureus|August 1, 2024
Familial Occurrence of a Severe Phenotype of Central Serous Chorioretinopathy in Two BrothersYuta Inada, Yoichi Sakurada, Taiyo Shijo, et al.
Scientific Reports|January 25, 2026
Two year outcomes of as needed brolucizumab therapy in exudative age related macular degeneration with or without pachychoroid phenotypeYoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal VasculopathyYoshiko Fukuda, Yoichi Sakurada, Yumi Kotoda, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2021
Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular EdemaWataru Kikushima, Taiyo Shijo, Yukiko Furuhata, et al.
Pageof 12